Advertisement
Organisation › Details
Celonic AG
Celonic, a global CDMO (contract development & manufacturing organization) for innovative biopharmaceuticals, including cell and gene therapy products, is part of the private and independent family-owned company J.RETTENMAIER & Söhne (JRS-Group), with currently two production sites – in Basel, Switzerland (headquarters) and Heidelberg, Germany. Celonic provides comprehensive development and manufacturing services for biotherapeutics including cell line development, USP and DSP development, GMP and non-GMP manufacturing of biopharmaceutical drug substances and drug products, along with cell expression platforms and diagnostics. With a new state-of-the-art GMP manufacturing facility for gene vectors and cell therapy, Celonic is expanding its existing ATMP development and GMP manufacturing capacity in the upcoming Life Science Park Rheintal in Stein, Switzerland. *
Start | 2006-01-01 renamed | |
Group | Celonic (Group) | |
Successor | Baliopharm GmbH | |
Industry | cell line development (recombinant protein production) | |
Industry 2 | contract manufacturing (biologicals) | |
Person | Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director) | |
Person 2 | Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion) | |
Region | Basel BS | |
Country | Switzerland | |
Street | 55 Eulerstr. | |
City | 4051 Basel | |
Tel | +41-61-654915-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2017-10-26) |
* Document for »About Section«: Celonic AG. (10/28/21). "Press Release: Alexandre Pasini Appointed Chief Operating Officer at Celonic". Basel. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Celonic (Group)
- [1] Celonic AG. (10/28/21). "Press Release: Alexandre Pasini Appointed Chief Operating Officer at Celonic". Basel....
- [2] Celonic AG. (2/25/21). "Press Release: Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland". Basel....
- [3] Celonic AG. (5/8/18). "Press Release: Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy". Basel....
- [4] Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top